Bionano Genomics, Inc.
NASDAQ:BNGO
0.195 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 17.948 | 5.091 | 24.571 | 38.449 | 17.311 | 16.523 | 1.022 | 5.25 |
| Short Term Investments
| 48.823 | 108.095 | 226.041 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 101.888 | 113.186 | 250.612 | 38.449 | 17.311 | 16.523 | 1.022 | 5.25 |
| Net Receivables
| 9.661 | 7.022 | 4.934 | 2.775 | 6.334 | 4.514 | 3.352 | 1.847 |
| Inventory
| 22.892 | 29.761 | 12.387 | 3.316 | 3.444 | 1.069 | 1.694 | 1.797 |
| Other Current Assets
| 7.107 | 7.329 | 4.481 | 1.104 | 0.759 | 0.92 | 1.072 | 1.842 |
| Total Current Assets
| 140.118 | 157.298 | 272.414 | 46.789 | 28.258 | 23.025 | 7.139 | 10.736 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 32.481 | 28.958 | 20.935 | 4.91 | 1.95 | 1.777 | 3.006 | 4.052 |
| Goodwill
| 0 | 77.289 | 56.16 | 7.173 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 33.974 | 41.143 | 26.842 | 1.475 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 33.974 | 118.432 | 83.002 | 8.647 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.4 | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| -0.4 | -0.4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 7.431 | 2.814 | 0.749 | 0.103 | -1.95 | 0 | 0 | 0 |
| Total Non-Current Assets
| 74.286 | 150.204 | 104.686 | 13.66 | 1.95 | 1.777 | 3.006 | 4.052 |
| Total Assets
| 214.404 | 307.502 | 377.1 | 60.45 | 30.208 | 24.802 | 10.145 | 14.788 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 10.384 | 12.534 | 9.696 | 2.93 | 2.699 | 1.352 | 2.303 | 0.792 |
| Short Term Debt
| 72.238 | 5.09 | 3.532 | 0 | 20.085 | 0 | 6.73 | 0.587 |
| Tax Payables
| 1.099 | 0.825 | 0.677 | 0.562 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0.871 | 0.684 | 0.416 | 0.357 | 0.271 | 0.212 | 0.447 |
| Other Current Liabilities
| 16.307 | 17.435 | 7.935 | 5.037 | 3.225 | 2.9 | 7.408 | 7.538 |
| Total Current Liabilities
| 100.028 | 35.884 | 21.84 | 8.944 | 26.305 | 4.523 | 16.652 | 9.364 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 7.175 | 9.123 | 8.93 | 16.326 | 0 | 9.029 | 0 | -19.37 |
| Deferred Revenue Non-Current
| 0.154 | 0.127 | 0.146 | 0.098 | 0.183 | 0.304 | 0.143 | 0.245 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | -0.098 | 0 | 0 | 0 | 25.417 |
| Other Non-Current Liabilities
| 10.89 | 12.97 | 9.066 | 0 | 0.152 | 0.808 | 43.577 | -24.441 |
| Total Non-Current Liabilities
| 18.219 | 22.22 | 18.142 | 16.423 | 0.335 | 10.142 | 43.72 | 32.683 |
| Total Liabilities
| 118.247 | 58.104 | 39.982 | 25.367 | 26.64 | 14.665 | 60.372 | 42.047 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 24,802.421 | 43.01 | 25.417 |
| Common Stock
| 0.005 | 0.03 | 0.029 | 0.019 | 0.003 | 0.001 | 0 | 0 |
| Retained Earnings
| -581.208 | -348.715 | -216.119 | -143.684 | -102.577 | -72.762 | -54.266 | -30.901 |
| Accumulated Other Comprehensive Income/Loss
| 0.023 | -1.124 | -0.539 | -0 | 0 | -5.162 | -3.922 | -2.418 |
| Other Total Stockholders Equity
| 677.337 | 599.207 | 553.747 | 178.747 | 106.188 | 82.899 | 7.96 | 6.059 |
| Total Shareholders Equity
| 96.157 | 249.398 | 337.118 | 35.082 | 3.614 | 10.137 | -50.227 | -27.259 |
| Total Equity
| 96.157 | 249.398 | 337.118 | 35.082 | 3.614 | 10.137 | -50.227 | -27.259 |
| Total Liabilities & Shareholders Equity
| 214.404 | 307.502 | 377.1 | 60.45 | 30.254 | 24.802 | 10.145 | 14.788 |